Sulfonylureas: Just Stop - Medscape
Aug 13, 2018 · Patients taking sulfonylureas as second-line therapy—replacing rather than adding on to metformin—had increased risks for myocardial infarction, all-cause mortality, and severe …
Sulfonylureas as Street Drugs: Hidden Hypoglycemia Cause
May 8, 2023 · In a new case report, a person presented to the emergency department with severe hypoglycemia caused by inadvertent sulfonylurea overdose. There have been similar cases.
Factitious Hypoglycemia - Page 6 - Medscape
May 8, 2002 · The actual incidence of sulfonylurea-induced-factitious hypoglycemia is not known. [3] Repaglinide, an oral antidiabetic drug, belongs to a new class of drugs known as prandial …
Awakening to the Dawn Phenomenon in Diabetes - Medscape
Nov 7, 2024 · Early morning hyperglycemia is sometimes called the “dawn phenomenon.” Left untreated, it can drive poorer outcomes. How can it be detected and managed?
Toxicology of Oral Antidiabetic Medications - Page 2 - Medscape
Hypoglycemics: Sulfonylureas The sulfonylureas remain one of the mainstays in the management of type 2 diabetes and are the most commonly used oral antidiabetic medications. [8, 11] Not ...
Thyroid Cancer Detections Due to More Screenings With GLP-1s
Jan 27, 2025 · The good news is that the risk for thyroid cancer linked to GLP-1 drugs appears low, but higher detections in the first year, when a causative role of the drug is implausible, …
Early Glycaemic Control in T2D Produces Long-Term Benefit
May 28, 2024 · Early initiation of intensive glycaemic control with metformin, insulin, or sulfonylureas in people with new-onset type 2 diabetes (T2D) continues to confer longevity …
Do SGLT2 Inhibitors Benefit Everyone With T2D and CKD?
Sep 10, 2024 · After multivariable adjustment, the hazard ratio for kidney disease progression with an SGLT2 inhibitor vs a DPP4 inhibitor/sulfonylurea was 0.60, consistent with that seen in …
Oral Antidiabetic Agents in Pregnancy and Lactation: A
Use of Oral Antidiabetic Agents in Breast-Feeding With the increasing incidence of type 2 diabetes in younger people, the incidence of women with type 2 diabetes in pregnancy is …
GLP-1 Agonists Reduce Recurrent Atrial Fibrillation - Medscape
May 16, 2025 · After propensity matching on the basis of 31 covariates, 1226 patients starting a GLP-1 were compared with 1284 of those taking either a DPP-4 inhibitor or sulfonylurea.